Skip to main content
Clinical Trials/NCT04512937
NCT04512937
Active, Not Recruiting
N/A

Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer

Oslo University Hospital1 site in 1 country20 target enrollmentSeptember 1, 2020
ConditionsRectal Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rectal Cancer
Sponsor
Oslo University Hospital
Enrollment
20
Locations
1
Primary Endpoint
Rate of patients with R0 resection
Status
Active, Not Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The aim of this study is to investigate feasibility of computer navigation-assisted surgery in particularly difficult cases of locally advanced (LARC) and recurrent (LRRC) rectal cancer where the standard surgical strategy is expected to result in incomplete tumour removal. The investigators hypothesize that computer navigation-assisted surgery can facilitate improved anatomic orientation in the pelvis enabling tumour removal with free margins in these cases.

Detailed Description

Curative treatment of rectal cancer requires surgical removal of the tumour. The key challenge in this surgery is to remove the tumour with free margins - R0 resection. Failure to achieve R0 resection often leads to recurrence, which is associated with risk of long-term suffering, poor quality of life and death for the patients. Achieving R0 resection is most difficult in advanced rectal cancer cases, where the tumour is threatening - and sometimes even growing into - neighbouring organs. Computer navigation-assisted surgery has typically been implemented where extreme surgical precision is necessary or in surgical fields with high anatomic complexity. In such settings, it contributes to preservation of vital anatomic structures close to the tumour, and ensures completeness of resection in cases of malignant disease. With this in mind, feasibility of navigation in surgically challenging rectal cancer cases will be investigated in this study. If found feasible, navigation could improve surgical management for patients who otherwise would not have the possibility of cure.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
September 1, 2027
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Kjersti Flatmark

Professor

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with LARC or LRRC (either biopsy verified, or demonstrated on MRI and confirmed by the MDT decision)
  • The MDT must deem standard surgical strategy at high risk of resulting in R1/R2 resection and computer-assisted navigation likely to improve the chances of obtaining R0 resection.
  • Written informed consent

Exclusion Criteria

  • Non-adenocarcinoma malignancies.
  • Unresectable distant metastatic disease or unresectable synchronous other malignancy
  • Patients deemed unfit to participation according to the MDT.

Outcomes

Primary Outcomes

Rate of patients with R0 resection

Time Frame: 2 years

Resection status will be determined by histopathological examination of specimen

Secondary Outcomes

  • Assessment of whether pre-procedural plan was executed during surgery by comparing pre- and post-operative magnetic resonance imaging (MRI).(2 years)
  • Assessment of whether pre-procedural plan was executed by comparing volume of intended resection with volume of resected specimen.(2 years)
  • Assessment of surgeons' opinion on benefit of computer navigation through qualitative interviews.(2 years)
  • Progression-free survivial (PFS)(5 years)
  • Occurrence of 30 day morbidity and mortality assessed with the Accordion severity grading system of surgical complications(30 days after surgery)
  • Assessment of patients quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)(3 years)
  • Overall survival (OS)(5 years)
  • Rate of local (re-)recurrence after surgery(5 years)

Study Sites (1)

Loading locations...

Similar Trials